We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

GlaxoSmithKline To Pay $92m To Settle Suits Over Patent Gaming

Law360 (July 12, 2004, 12:00 AM EDT) -- U.K. drug maker GlaxoSmithKline has agreed to pay $92 million to settle a series of antitrust lawsuits targeting its alleged “gaming” of the patents covering antibiotic prescription drug Augmentin.

GlaxoSmithKline said the payment will settle class action lawsuits dating back to 2002, and that it will take a legal charge of $315 million during second quarter earnings.

Still outstanding is a lawsuit against GlaxoSmithKline brought by one of the generic makers, Lek Pharmaceuticals, a company based in Slovenia that is a subsidiary of Novartis AG....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.